Sun Pharma Share Price Today, Sun Pharma Stock Price Live NSE/BSE
Sun Pharmaceutical Industries Share Price
View All
Do you find these insights useful?
| (x) | 36.92 |
| (₹) | 45.61 |
| (₹ Cr.) | 4,03,952 |
| 1 | |
| (x) | 6.15 |
| (%) | 0.80 |
| (₹) | 1.00 |
| 0.00 | |
| (₹) | 1,668.62 |
| 1 Day | -2.05% |
| 1 Week | -2.96% |
| 1 Month | -5.88% |
| 3 Months | 2.42% |
| 1 Year | 12.61% |
| 3 Years | 82.59% |
| 5 Years | 258.67% |
BUY
Current
Mean Recos by Analysts
Strong
SellSellHoldBuyStrong
Buy
| Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
|---|---|---|---|---|
| Strong Buy | 12 | 13 | 13 | 12 |
| Buy | 13 | 12 | 12 | 13 |
| Hold | 4 | 4 | 4 | 6 |
| Sell | 3 | 2 | 2 | 2 |
| Strong Sell | - | - | - | - |
| # Analysts | 32 | 31 | 31 | 33 |
| Quarterly | Annual | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|
| Total Income | 13,571.71 | 14,141.08 | 13,645.39 | 13,185.30 | 12,588.84 |
| Total Income Growth (%) | -4.03 | 3.63 | 3.49 | 4.74 | -0.33 |
| Total Expenses | 10,268.22 | 10,613.17 | 9,978.34 | 9,700.26 | 9,699.75 |
| Total Expenses Growth (%) | -3.25 | 6.36 | 2.87 | 0.01 | 1.08 |
| EBIT | 3,303.49 | 3,527.91 | 3,667.05 | 3,485.04 | 2,889.09 |
| EBIT Growth (%) | -6.36 | -3.79 | 5.22 | 20.63 | -4.81 |
| Profit after Tax (PAT) | 2,153.93 | 2,912.98 | 3,040.16 | 2,835.62 | 2,654.58 |
| PAT Growth (%) | -26.06 | -4.18 | 7.21 | 6.82 | 5.18 |
| EBIT Margin (%) | 24.34 | 24.95 | 26.87 | 26.43 | 22.95 |
| Net Profit Margin (%) | 15.87 | 20.60 | 22.28 | 21.51 | 21.09 |
| Basic EPS (₹) | 9.00 | 12.10 | 12.70 | 11.80 | 11.10 |
| Quarterly | Annual | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|
| Total Income | 7,317.74 | 6,260.20 | 5,214.01 | 4,580.81 | 5,758.02 |
| Total Income Growth (%) | 16.89 | 20.06 | 13.82 | -20.44 | 11.79 |
| Total Expenses | 4,488.24 | 4,779.31 | 4,074.62 | 4,106.81 | 4,138.65 |
| Total Expenses Growth (%) | -6.09 | 17.29 | -0.78 | -0.77 | -1.09 |
| EBIT | 2,829.50 | 1,480.89 | 1,139.39 | 474.00 | 1,619.37 |
| EBIT Growth (%) | 91.07 | 29.97 | 140.38 | -70.73 | 67.57 |
| Profit after Tax (PAT) | 2,000.46 | 1,181.05 | 863.29 | 237.82 | 867.60 |
| PAT Growth (%) | 69.38 | 36.81 | 263.00 | -72.59 | 20.28 |
| EBIT Margin (%) | 38.67 | 23.66 | 21.85 | 10.35 | 28.12 |
| Net Profit Margin (%) | 27.34 | 18.87 | 16.56 | 5.19 | 15.07 |
| Basic EPS (₹) | 8.30 | 4.90 | 3.60 | 1.00 | 3.60 |
| Quarterly | Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 54,543.48 | 49,851.04 | 44,520.20 | 39,576.00 | 34,333.66 |
| Total Revenue Growth (%) | 9.41 | 11.97 | 12.49 | 15.27 | 2.57 |
| Total Expenses | 40,113.50 | 38,268.83 | 34,940.32 | 30,527.86 | 27,228.15 |
| Total Expenses Growth (%) | 4.82 | 9.53 | 14.45 | 12.12 | -3.46 |
| Profit after Tax (PAT) | 10,964.75 | 9,576.38 | 8,473.58 | 3,272.73 | 2,903.82 |
| PAT Growth (%) | 14.50 | 13.01 | 158.91 | 12.70 | -22.87 |
| Operating Profit Margin (%) | 27.88 | 24.37 | 22.22 | 23.73 | 21.63 |
| Net Profit Margin (%) | 20.85 | 19.74 | 19.30 | 8.46 | 8.66 |
| Basic EPS (₹) | 45.60 | 39.90 | 35.30 | 13.60 | 12.10 |
| Quarterly | Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 23,372.76 | 20,740.93 | 21,091.17 | 16,543.90 | 12,953.43 |
| Total Revenue Growth (%) | 12.69 | -1.66 | 27.49 | 27.72 | -7.76 |
| Total Expenses | 18,342.19 | 17,072.26 | 16,412.33 | 14,416.51 | 10,711.00 |
| Total Expenses Growth (%) | 7.44 | 4.02 | 13.84 | 34.60 | -0.73 |
| Profit after Tax (PAT) | 4,282.62 | 2,858.18 | 1,690.72 | -99.99 | 2,139.70 |
| PAT Growth (%) | 49.84 | 69.05 | - | -104.67 | -33.37 |
| Operating Profit Margin (%) | 25.75 | 21.96 | 24.75 | 16.13 | 19.52 |
| Net Profit Margin (%) | 18.61 | 14.09 | 8.12 | -0.64 | 16.71 |
| Basic EPS (₹) | 17.80 | 11.90 | 7.00 | -0.40 | 8.92 |
All figures in Rs Cr, unless mentioned otherwise
Do you find these insights useful?
START FREE TRIAL
Do you find these insights useful?
MF Ownership as on 30 April 2025
Price
1,681.60-42.00 (-2.44%)
Open Interest
1,29,53,500-3,246,950 (-20.04%)
| Open | High | Low | Prev Close | Contracts Traded | Turnover (₹ Lakhs) |
|---|---|---|---|---|---|
| 1,668.40 | 1,686.20 | 1,637.80 | 1,723.60 | 24,885 | 1,45,087.82 |
Open Interest as of 23 May 2025
Price
9.10-32.10 (-77.91%)
Open Interest
23,83,8504,03,550 (20.38%)
| Open | High | Low | Prev Close | Contracts Traded | Turnover (₹ Lakhs) |
|---|---|---|---|---|---|
| 10.80 | 11.90 | 4.40 | 41.20 | 38,650 | 2,31,002.35 |
Open Interest as of 23 May 2025
All Types Ex-Date Record Date Announced on Details Bonus Jul 29, 2013 Jul 30, 2013 May 28, 2013 Bonus Ratio: 1 share(s) for every 1 shares held Splits Nov 25, 2010 Nov 26, 2010 Sep 24, 2010 Split: Old FV5.0| New FV:1.0 Bonus May 27, 2004 May 29, 2004 Apr 21, 2004 Bonus Ratio: 1 share(s) for every 1 shares held Splits Jan 13, 2003 Jan 21, 2003 Oct 28, 2002 Split: Old FV10.0| New FV:5.0 Bonus Mar 06, 2000 Mar 23, 2000 Feb 09, 2000 Bonus Ratio: 2 share(s) for every 1 shares held
Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 4,03,952.04 Crore) operating in Pharmaceuticals sector. Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2024. Show More
DS
Dilip S Shanghvi
Chairman & Managing Director
AG
Abhay Gandhi
CEO - North America
SD
S Damodharan
CEO - API Business
UB
Uday Baldota
CEO - Taro Pharmaceutical Industries Ltd.
AD
Aalok D Shanghvi
Whole Time Director
SV
Sudhir V Valia
Non Exe.Non Ind.Director
Show More
Key Indices Listed on
Nifty 50, BSE Sensex, Nifty 100, + 48 more
Address
Sun Pharma Advanced Research Centre (SPARC),Tandalja,Vadodra, Gujarat - 390012
Sun Pharma
Revital
Show More
1. What's Sun Pharma share price today and what are Sun Pharma share returns ?
Sun Pharma share price is Rs 1,683.60 as on 23 May, 2025, 03:59 PM IST. Sun Pharma share price is down by 2.05% based on previous share price of Rs 1,731.8. Sun Pharma share price trend:
- Last 1 Month: Sun Pharma share price moved down by 5.88%
- Last 12 Months: Sun Pharma share price moved up 12.61%
- Last 3 Years: Sun Pharma Share price moved up by 82.59%
2. What are the key metrics to analyse Sun Pharma Share Price?
Sun Pharma share can be quickly analyzed on following metrics:
- Stock's PE is 36.92
- Price to Book Ratio of 6.15
3. What is the market cap of Sun Pharma?
Within the Pharmaceuticals sector, Sun Pharma stock has a market cap rank of 1. Sun Pharma has a market cap of Rs 4,03,952 Cr.
4. Who are the key owners of Sun Pharma stock?
- Promoter holding has not changed in last 9 months and holds 54.48 stake as on 31 Mar 2025
- Domestic Institutional Investors holding have gone down from 19.08 (30 Jun 2024) to 18.48 (31 Mar 2025)
- Foreign Institutional Investors holding has gone up from 17.23 (30 Jun 2024) to 17.95 (31 Mar 2025)
- Other investor holding have gone down from 9.21 (30 Jun 2024) to 9.09 (31 Mar 2025)
5. What are the returns for Sun Pharma share?
Return Performance of Sun Pharma Shares:
- 1 Week: Sun Pharma share price moved down by 2.96%
- 1 Month: Sun Pharma share price moved down by 5.88%
- 6 Month: Sun Pharma share price moved down by 6.22%
6. What is the CAGR of Sun Pharma?
The CAGR of Sun Pharma is 9.69.
7. Which are the key peers to Sun Pharma?
Top 10 Peers for Sun Pharma are Divi's Laboratories Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Mankind Pharma Ltd., Zydus Lifesciences Ltd., Lupin Ltd., Aurobindo Pharma Ltd., Alkem Laboratories Ltd. and Biocon Ltd.
8. What has been highest price of Sun Pharma share in last 52 weeks?
In last 52 weeks Sun Pharma share had a high price of Rs 1,960.35 and low price of Rs 1,377.20
9. Who is the Chief Executive Officer of Sun Pharma?
Abhay Gandhi is the CEO - North America of Sun Pharma
10. What are the Sun Pharma quarterly results?
Total Revenue and Earning for Sun Pharma for the year ending 2024-03-31 was Rs 49851.04 Cr and Rs 9576.38 Cr on Consolidated basis. Last Quarter 2025-03-31, Sun Pharma reported an income of Rs 13571.71 Cr and profit of Rs 2153.93 Cr.
11. What is the PE & PB ratio of Sun Pharma?
The PE ratio of Sun Pharma stands at 36.04, while the PB ratio is 6.15.
12. What dividend is Sun Pharma giving?
An equity Interim dividend of Rs 10.5 per share was declared by Sun Pharmaceutical Industries Ltd. on 16 Jan 2025. So, company has declared a dividend of 1050% on face value of Rs 1 per share. The ex dividend date was 06 Feb 2025.
Top Losers As on 03:59 PM | 23 May 2025
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.
